Rom E. Eliaz

941 total citations
12 papers, 799 citations indexed

About

Rom E. Eliaz is a scholar working on Molecular Biology, Biomaterials and Genetics. According to data from OpenAlex, Rom E. Eliaz has authored 12 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Biomaterials and 3 papers in Genetics. Recurrent topics in Rom E. Eliaz's work include RNA Interference and Gene Delivery (4 papers), Glycosylation and Glycoproteins Research (2 papers) and Virus-based gene therapy research (2 papers). Rom E. Eliaz is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Glycosylation and Glycoproteins Research (2 papers) and Virus-based gene therapy research (2 papers). Rom E. Eliaz collaborates with scholars based in Israel, United States and Switzerland. Rom E. Eliaz's co-authors include Francis C. Szoka, Joseph Kost, Shlomo Nir, Cornelia Marty, David Wallach, Eli Eyal, David Wallach, Victor Abler, Robert A. Hauser and Hussein Hallak and has published in prestigious journals such as Brain, Cancer Research and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Rom E. Eliaz

12 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rom E. Eliaz Israel	10	363	336	181	178	112	12	799
Igor Skidan United States	9	510 1.4×	588 1.8×	293 1.6×	247 1.4×	44 0.4×	10	1.2k
Rebecca Klippstein United Kingdom	17	337 0.9×	312 0.9×	279 1.5×	68 0.4×	27 0.2×	24	880
Chantal C.M. Appeldoorn Netherlands	16	550 1.5×	339 1.0×	146 0.8×	126 0.7×	23 0.2×	22	976
Lucia Bondioli Italy	13	313 0.9×	300 0.9×	155 0.9×	155 0.9×	23 0.2×	17	698
Xianying Zhang China	9	298 0.8×	317 0.9×	134 0.7×	207 1.2×	43 0.4×	25	793
Simón Guerrero Chile	15	396 1.1×	359 1.1×	246 1.4×	84 0.5×	26 0.2×	25	979
Vijay Sagar Madamsetty United States	17	464 1.3×	333 1.0×	359 2.0×	89 0.5×	25 0.2×	31	1.1k
Dean S.T. Hsieh United States	11	202 0.6×	182 0.5×	164 0.9×	340 1.9×	28 0.3×	17	864
Michael R. Ziebell United States	15	603 1.7×	229 0.7×	146 0.8×	82 0.5×	335 3.0×	18	1.2k
Janet L. Manias Canada	13	499 1.4×	223 0.7×	121 0.7×	95 0.5×	69 0.6×	15	941

Countries citing papers authored by Rom E. Eliaz

Since Specialization

Citations

This map shows the geographic impact of Rom E. Eliaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rom E. Eliaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rom E. Eliaz more than expected).

Fields of papers citing papers by Rom E. Eliaz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rom E. Eliaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rom E. Eliaz. The network helps show where Rom E. Eliaz may publish in the future.

Co-authorship network of co-authors of Rom E. Eliaz

This figure shows the co-authorship network connecting the top 25 collaborators of Rom E. Eliaz. A scholar is included among the top collaborators of Rom E. Eliaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rom E. Eliaz. Rom E. Eliaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Gilgun‐Sherki, Yossi, Rom E. Eliaz, David J. McCann, et al.. (2016). Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence. Drug and Alcohol Dependence. 166. 13–20. 32 indexed citations

2.

Masellis, Mario, S.Karen Collinson, Natalie Freeman, et al.. (2016). Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson’s disease: a pharmacogenetic study. Brain. 139(7). 2050–2062. 49 indexed citations

3.

Hauser, Robert A., Victor Abler, Eli Eyal, & Rom E. Eliaz. (2016). Efficacy of rasagiline in early Parkinson's disease: a meta-analysis of data from the TEMPO and ADAGIO studies. International Journal of Neuroscience. 126(10). 942–946. 15 indexed citations

4.

Eliaz, Rom E. & Joseph Kost. (2005). Applications of injectable polymeric implants for protein and DNA delivery. Israel Journal of Chemistry. 45(4). 437–444. 1 indexed citations

5.

Eliaz, Rom E., Shlomo Nir, & Francis C. Szoka. (2004). Interactions of Hyaluronan-Targeted Liposomes with Cultured Cells: Modeling of Binding and Endocytosis. Methods in enzymology on CD-ROM/Methods in enzymology. 387. 16–33. 28 indexed citations

6.

Eliaz, Rom E., Shlomo Nir, Cornelia Marty, & Francis C. Szoka. (2004). Determination and Modeling of Kinetics of Cancer Cell Killing by Doxorubicin and Doxorubicin Encapsulated in Targeted Liposomes. Cancer Research. 64(2). 711–718. 127 indexed citations

7.

Eliaz, Rom E. & Francis C. Szoka. (2002). Robust and prolonged gene expression from injectable polymeric implants. Gene Therapy. 9(18). 1230–1237. 39 indexed citations

8.

Eliaz, Rom E. & Francis C. Szoka. (2001). Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.. PubMed. 61(6). 2592–601. 298 indexed citations

9.

Eliaz, Rom E., David Wallach, & Joseph Kost. (2000). Delivery of Soluble Tumor Necrosis Factor Receptor from In-Situ Forming PLGA Implants: In-Vivo. Pharmaceutical Research. 17(12). 1546–1550. 44 indexed citations

10.

Eliaz, Rom E. & Joseph Kost. (2000). Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins. Journal of Biomedical Materials Research. 50(3). 388–396. 141 indexed citations

11.

Eliaz, Rom E. & Joseph Kost. (2000). Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins. Journal of Biomedical Materials Research. 50(3). 388–388. 7 indexed citations

12.

Eliaz, Rom E., David Wallach, & Joseph Kost. (1996). LONG-TERM PROTECTION AGAINST THE EFFECTS OF TUMOUR NECROSIS FACTOR BY CONTROLLED DELIVERY OF THE SOLUBLE p55 TNF RECEPTOR. Cytokine. 8(6). 482–487. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact